Skip to content
Trending
August 24, 2025Lowe’s beats on quarterly earnings, buys home pros business for $8.8 billion April 22, 2025Retail sales increased 1.4% in March, greater than expected November 1, 2025Interest rate backdrop supports playing offense with bonds, according to Goldman Sachs former ETF head December 7, 2025David Ellison’s hunt for WBD made David Zaslav richer — and it may not be over April 24, 2025Tide owner Procter & Gamble cuts earnings, revenue outlook as quarterly sales disappoint May 18, 2025Consumer sentiment slides to second-lowest on record as inflation expectations jump after tariffs July 29, 2025The EU-U.S. trade deal could have one unexpected winner: The UK October 10, 2025Why Wall Street’s old ‘wall of worry’ and new ‘debasement trade’ are boosting gold, bitcoin in typically volatile October February 2, 2025Will 2025 finally mark the end of the IPO drought? August 22, 2025Russia weighs in on U.S.-India tariff spat, saying New Delhi can choose its own trade partners
  Saturday 8 August 2026
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
  Earnings  Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
Earnings

Walgreens tops estimates as drugstore chain cuts costs, prepares to go private

AdminAdmin—April 8, 20250

More stories

Walmart’s worst week since 2022: Retailer’s former U.S. CEO Bill Simon thinks Wall Street is getting earnings, tariff risks wrong

February 23, 2025

Atlassian closes at highest since 2022 after reporting better-than-expected earnings, revenue outlook

February 3, 2025

Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives ‘hope’

July 23, 2025

Nestle announces plans to slash 16,000 jobs, stock jumps 9%

October 18, 2025

A sign for US drugstore chain Walgreens is displayed outside its store in New York City on March 7, 2025.

Angela Weiss | AFP | Getty Images

Walgreens on Tuesday reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant benefits from cost cuts and prepares to go private.

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.

Here’s what Walgreens reported for the three-month period ended Feb. 28 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: 63 cents adjusted vs. 53 cents expected
  • Revenue: $38.59 billion vs. $38 billion expected

This story is developing. Please check back for updates.

Fake job seekers are flooding U.S. companies that are hiring for remote positions, tech CEOs say
CEOs think the U.S. is ‘probably in a recession right now,’ says BlackRock’s Larry Fink
Related posts
  • Related posts
  • More from author
Earnings

Google cloud growth tops Microsoft and Amazon as all three beat estimates on AI demand

May 2, 20260
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Earnings

Salesforce’s raised guidance lifts the stock but doesn’t change our rating

December 17, 20250
Load more
Read also
Earnings

Google cloud growth tops Microsoft and Amazon as all three beat estimates on AI demand

May 2, 20260
Finance

Visa says new AI shopping tool has helped customers with hundreds of transactions

December 18, 20250
Economy

Trust these numbers? Economists see a lot of flaws in delayed CPI report showing downward inflation

December 18, 20250
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Business

American Airlines no longer lets basic economy flyers earn miles

December 18, 20250
Finance

Billionaire fund manager Ron Baron praises beaten-up financial stock whose new CEO he compares to Jamie Dimon

December 17, 20250
Load more
    © 2022, All Rights Reserved.
    • About Us
    • Advertise With Us
    • Contact Us
    • Disclaimer
    • Cookie Law
    • Privacy Policy
    • Terms & Conditions